Ignota Labs is using AI to fix failed drugs and bring them to market. It raised $6.9 million from investors with this pitch ...

Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and ...

This streamlined approach not only accelerates the drug discovery pipeline but also improves the overall success rate of identifying viable drug targets. The AI-Powered Target Identification Service ...

Experts say the approach could also save millions of pounds by cutting projects or clinical trials that would otherwise fail.

Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform.

During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing ...

Learn how AI-driven TechBio is revolutionizing biotech in our exclusive interview with Bullfrog AI CEO Vin Singh.

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

Valo Health, Inc. ("Valo"), a biotechnology company focused on transforming the drug discovery and development process using ...